Effective Enhancement of Hypoglycemic Effect of Insulin by Liver-Targeted Nanoparticles Containing Cholic Acid-Modified Chitosan Derivative
Authors:
- 17 June 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 13 (7) , 2433-2442
Abstract
Liver is responsible for the balance of blood glucose level. In this study, cholic acid and N-(2-hydroxy)-propyl-3-trimethylammonium chloride modified chitosan (HTCC-CA) was used as a liver-targeted vehicle for insulin delivery. A novel approach was developed to effectively load insulin by mixing insulin and HTCC-CA in 50% ethanol and water mixed solvent at pH 2 and then dialysis against pH 7.4 phosphate buffer subsequently against water. The insulin-loaded HTCC-CA nanoparticles have an average diameter of 86 nm and insulin loading efficiency of 98.7%. Due to random distribution of the hydrophobic cholic acid groups in HTCC-CA, some of the cholic acid groups located on the nanoparticle surface. Compared with free insulin, the nanoparticles increased in vitro cellular uptake of insulin to 466%, and the nanoparticles accumulated in liver for more time after subcutaneous injection into mice. The therapy for diabetic rats displayed that the nanoparticles increased the pharmacological bioavailability of insulin to 475% relative to free insulin, and the nanoparticles could maintain the hypoglycemic effect for more than 24 h. This study demonstrates that the nanoparticles with cholic acid groups on their surface possess liver-targeted property and biocompatible insulin-loaded HTCC-CA nanoparticles can effectively enhance the hypoglycemic effect of insulin.Keywords
Funding Information
- National Natural Science Foundation of China (21474018)
- Ministry of Science and Technology of China (2011CB932503)
This publication has 42 references indexed in Scilit:
- Emerging micro- and nanotechnology based synthetic approaches for insulin deliveryChemical Society Reviews, 2014
- Advanced progress of microencapsulation technologies: In vivo and in vitro models for studying oral and transdermal drug deliveriesJournal of Controlled Release, 2014
- Oral delivery of proteins by biodegradable nanoparticlesAdvanced Drug Delivery Reviews, 2013
- Chitosan–zinc–insulin complex incorporated thermosensitive polymer for controlled delivery of basal insulin in vivoJournal of Controlled Release, 2012
- An overview of natural polymers for oral insulin deliveryDrug Discovery Today, 2012
- A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticlesBiomaterials, 2012
- Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and managementWorld Journal of Gastroenterology, 2009
- The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticlesBiomaterials, 2008
- Global and societal implications of the diabetes epidemicNature, 2001
- Signaling pathways in insulin action: molecular targets of insulin resistanceJournal of Clinical Investigation, 2000